Remove 2023 Remove Hospice Remove Medicare Remove Personal care
article thumbnail

Addus Sees Hospice Improvements, Plans to Rebalance Home Health-Personal Care M&A Activity

Hospice News

Addus HomeCare Corporation’s (NASDAQ: ADUS) hospice segment is seeing slow but steady improvement as pandemic headwinds ease. Meanwhile, the company’s near-term acquisition sights are set more on home health than in personal care amid potential payment shifts. We believe that hospice volumes will continue to steadily improve.”

article thumbnail

How Home Health, Personal Care Reimbursement Guiding Addus’ M&A Strategy

Hospice News

As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its home health and personal care services, with hospice becoming less of a priority.

professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

4 Ways Hospices Are Pursuing Growth in 2023

Hospice News

Hospices are blazing trails toward growth, each provider with its own range of strategies. In 2023, the focus for many is to not only expand their core business but to spread further into the care continuum. By 2030, the hospice market’s total dollar value is expected to nearly double, reaching $64.7 billion, up from $34.5

2023 246
article thumbnail

Hospice Investors to Watch in 2024

Hospice News

Though the number of hospice M&A deals plummeted in 2023 compared to prior years, deals are still being made, and the industry may see a rebound in 2024. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. NYSE: HUM) for $2.8

2024 279
article thumbnail

How the 2023 Home Health Rule Could Change the Game in Hospice M&A

Hospice News

The pendulum of investor interest has swung hard into the hospice market in recent years, but shifts in reimbursement could steer buyers towards home health. Uncertainty earlier this year around Medicare’s proposed 2023 home health payment rates led some stakeholders to expect a swerve towards hospice.

2023 189
article thumbnail

Gentiva Inks Deal to Acquire Heartland Hospice from ProMedica for $710 Million

Hospice News

The hospice, palliative care and personal care provider Gentiva has agreed to acquire Heartland Hospice and other assets from the home-based care company ProMedica. The Atlanta-based provider emerged from the former hospice and personal care segments of Kindred at Home. Census Bureau.

Hospice 246
article thumbnail

Humana Set Sights on Value-Based Expansion Following Kindred Hospice Sale

Hospice News

As the dust settles from its divestiture of Kindred at Home’s hospice and personal care segments, Humana Inc. NYSE: HUM) seeks to further expand into value-based care as both a provider and a payer. Kindred Hospice pushed up Humana’s Q3 operating costs by roughly 160 basis and 200 basis points year-to-date.

Hospice 246